In 2018 Vasomune Therapeutics will be at the 36TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

36th Annual JPM Healthcare Conference
- Post author:gtmrick
- Post published:December 25, 2017
- Post category:Uncategorized
You Might Also Like

Vasomune Therapeutics Appoints Meenu Chhabra to its Board of Directors

Vasomune Receives a US $2.8 Million PRMRP Grant from the US Department of Defense to Develop AV-001 for the Treatment of ALI/ARDS of Any Cause, Including COVID-19
